ALAMEDA, Calif. , July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026....
First and only CAVT device for stroke demonstrated high revascularization rates, short procedure times and low complication rates
Globus Medical, Inspire Medical Systems, and Penumbra show varied revenue growth and analyst ratings, offering medical device investors alternatives to traditional pharmaceutical stocks.
ALAMEDA, Calif. , July 7, 2026 /PRNewswire/ -- Penumbra, Inc . (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world...
The THUNDERBOLT TM Computer Assisted Vacuum Thrombectomy (CAVT TM ) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid,...
THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal
ALAMEDA, Calif. , May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026.
Barchart Research What to Expect from PEN Earnings PEN Generated May 5, 2026 Current Price $323.86 EPS Estimate $$1.11 Consensus Rating Hold Average Move 8.04% Penumbra's First Quarter Without Guidance...